90 related articles for article (PubMed ID: 24435810)
21. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
Ward JF; Blute ML; Slezak J; Bergstralh EJ; Zincke H
J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
[TBL] [Abstract][Full Text] [Related]
22. Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage.
Poloyac SM; Reynolds RB; Yonas H; Kerr ME
J Neurosci Methods; 2005 Jun; 144(2):257-63. PubMed ID: 15910986
[TBL] [Abstract][Full Text] [Related]
23. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
[TBL] [Abstract][Full Text] [Related]
24. Identification and quantification of metabolites of arachidonic acid from cultures of endothelial cells by HPLC-MS2.
Zelinski V; Borlak J
Xenobiotica; 2005 Aug; 35(8):811-23. PubMed ID: 16278193
[TBL] [Abstract][Full Text] [Related]
25. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
26. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
Briganti A; Joniau S; Gontero P; Abdollah F; Passoni NM; Tombal B; Marchioro G; Kneitz B; Walz J; Frohneberg D; Bangma CH; Graefen M; Tizzani A; Frea B; Karnes RJ; Montorsi F; Van Poppel H; Spahn M
Eur Urol; 2012 Mar; 61(3):584-92. PubMed ID: 22153925
[TBL] [Abstract][Full Text] [Related]
27. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients.
Bruegel M; Ludwig U; Kleinhempel A; Petros S; Kortz L; Ceglarek U; Holdt LM; Thiery J; Fiedler GM
Crit Care Med; 2012 May; 40(5):1478-86. PubMed ID: 22511130
[TBL] [Abstract][Full Text] [Related]
28. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.
Kanoh Y; Akahoshi T; Ohara T; Ohtani N; Mashiko T; Ohtani S; Egawa S; Baba S
Anticancer Res; 2002; 22(3):1813-7. PubMed ID: 12168874
[TBL] [Abstract][Full Text] [Related]
31. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml.
Lucarelli G; Fanelli M; Larocca AM; Germinario CA; Rutigliano M; Vavallo A; Selvaggi FP; Bettocchi C; Battaglia M; Ditonno P
Prostate; 2012 Nov; 72(15):1611-21. PubMed ID: 22430630
[TBL] [Abstract][Full Text] [Related]
32. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
33. Analysis of blood HETE levels by selected ion monitoring with ricinoleic acid as the internal standard.
Walenga RW; Boone S; Stuart MJ
Prostaglandins; 1987 Nov; 34(5):733-48. PubMed ID: 3432563
[TBL] [Abstract][Full Text] [Related]
34. Changes of proteases and proteinase inhibitors in androgen-dependent advanced prostate cancer patients with alpha2-macroglobulin deficiency.
Kanoh Y; Ohtani H; Egawa S; Baba S; Akahoshi T
Clin Lab; 2012; 58(3-4):217-25. PubMed ID: 22582494
[TBL] [Abstract][Full Text] [Related]
35. Serum polyunsaturated fatty acid metabolites as useful tool for screening potential biomarker of colorectal cancer.
Zhang LJ; Chen B; Zhang JJ; Li J; Yang Q; Zhong QS; Zhan S; Liu H; Cai C
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():25-31. PubMed ID: 28515019
[TBL] [Abstract][Full Text] [Related]
36. Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome.
Zu L; Guo G; Zhou B; Gao W
Thromb Res; 2016 Aug; 144():192-201. PubMed ID: 27393924
[TBL] [Abstract][Full Text] [Related]
37. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
38. Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy.
Iacopino F; Pinto F; Bertaccini A; Calarco A; Proietti G; Totaro A; Martorana G; Bassi P; Sica G
Oncol Rep; 2012 Jul; 28(1):370-4. PubMed ID: 22552350
[TBL] [Abstract][Full Text] [Related]
39. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
[TBL] [Abstract][Full Text] [Related]
40. Serum free fatty acid biomarkers of lung cancer.
Liu J; Mazzone PJ; Cata JP; Kurz A; Bauer M; Mascha EJ; Sessler DI
Chest; 2014 Sep; 146(3):670-679. PubMed ID: 24743744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
